We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 3,770 results
  1. EQ-5D-3L and EQ-5D-5L population norms for Thailand

    Background

    The previous Thai norm-based scores for the EQ-5D-5L were established with Thai general population samples aged 20–70 years in 2019....

    Krittaphas Kangwanrattanakul, Christian U. Krägeloh in BMC Public Health
    Article Open access 22 April 2024
  2. Normative profile of the EQ-5D-5L dimensions, EQ-5D-5L index and EQ-VAS scores for the general Thai population

    Purpose

    To generate a normative profile for the EQ-5D-5L dimensions, EQ-5D-5L index, and EQ-VAS scores of the general Thai population and to examine...

    Krittaphas Kangwanrattanakul in Quality of Life Research
    Article 15 April 2023
  3. Population norms for the EQ-5D-3L and EQ-5D-5L in Romania

    Background

    The majority of patient reported outcome measures (PROMs) don’t have population norms in Romania. This is the case with the EQ-5D as well....

    Elena Olariu, Raluca Caplescu, ... Marian Sorin Paveliu in Health and Quality of Life Outcomes
    Article Open access 29 July 2023
  4. Assessing health state utilities for people with myalgic encephalomyelitis/chronic fatigue syndrome in Australia using the EQ-5D-5L, AQoL-8D and EQ-5D-5L-psychosocial instruments

    Purpose

    Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a chronic condition with a constellation of symptoms presenting as severe and...

    Nneka C. Orji, Ingrid A. Cox, ... Julie A. Campbell in Quality of Life Research
    Article Open access 10 August 2023
  5. The EQ-5D-5L valuation study for Trinidad and Tobago

    Purpose

    The 2016 EQ-5D-3L value set for Trinidad and Tobago (T&T) allows for the calculation of EQ-5D-5L values via the crosswalk algorithm. The 2016...

    Henry Bailey, Marcel F. Jonker, ... Bram Roudijk in Health and Quality of Life Outcomes
    Article Open access 02 July 2024
  6. Psychometric Properties of the EQ-5D-5L in Patients with Alopecia Areata

    Background

    For many decision makers in Health Technology Assessment the EQ-5D-5L is the standard measure of health-related quality of life (HRQL)....

    Andrew Lloyd, Daniel Aggio, ... Thomas Price in PharmacoEconomics - Open
    Article Open access 06 July 2024
  7. EQ-5D-5L Value Set for Slovenia

    Objectives

    The aim of this valuation study was to produce a value set to support the use of EQ-5D-5L data in decision making in Slovenia.

    ...
    Valentina Prevolnik Rupel, Marko Ogorevc in PharmacoEconomics
    Article Open access 21 June 2023
  8. Population Norms for the EQ-5D-5L, PROPr and SF-6D in Hungary

    Objectives

    This study aimed to develop population norms for three preference-accompanied measures [EQ-5D-5L, Patient-Reported Outcomes Measurement...

    Anna Nikl, Mathieu F. Janssen, ... Fanni Rencz in PharmacoEconomics
    Article Open access 28 February 2024
  9. EQ-5D-5L Portuguese population norms

    Objectives

    The EQ-5D-5L is a generic preference-based quality-of-life measure for which the corresponding Portuguese population value set was only...

    Pedro L. Ferreira, Luís N. Pereira, ... Lara N. Ferreira in The European Journal of Health Economics
    Article 11 January 2023
  10. A head-to-head comparison of the measurement properties of EQ-5D-3L and EQ-5D-5L in Chinese family caregivers of cancer patients

    Background

    Although both EQ-5D-3L(3L) and EQ-5D-5L(5L) have demonstrated good measurement properties in several patient populations, there is...

    Huan Zhang, Bo Liu, ... Nan Luo in Supportive Care in Cancer
    Article 07 December 2023
  11. Canada population norms for the EQ-5D-5L

    Objective

    In Canada, population norms are only available for 2 provinces, Alberta and Quebec. The objective of this study was to derive the population...

    Jiajun Yan, Shitong **e, ... Feng **e in The European Journal of Health Economics
    Article 24 February 2023
  12. Psychometric performance of EQ-5D-5L and SF-6Dv2 in patients with lymphoma in China

    Aim

    To assess and compare the measurement properties of EQ-5D-5L and SF-6Dv2 among lymphoma patients in China.

    Methods

    A face-to-face survey of...

    Aixue Zhang, **g Li, ... Pei Wang in The European Journal of Health Economics
    Article 07 March 2024
  13. Estimating the Relationship Between EQ-5D-5L and EQ-5D-3L: Results from a UK Population Study

    Objectives

    The aim of this study was to estimate the relationship between EQ-5D-3L and EQ-5D-5L, in both directions, using a single model.

    ...
    Mónica Hernández Alava, Steve Pudney, Allan Wailoo in PharmacoEconomics
    Article Open access 30 November 2022
  14. Measurement properties of the EQ-5D-3L, EQ-5D-5L, and SF-6Dv2 in patients with late-onset Pompe disease

    Objective

    The objective of this study was to evaluate the psychometric properties of the EQ-5D (3L and 5L) and SF-6Dv2 in a group of Chinese patients...

    Richard Huan Xu, Nan Luo, Dong Dong in The European Journal of Health Economics
    Article Open access 12 March 2024
  15. Estimating the disutility of relapse in relapsing–remitting and secondary progressive multiple sclerosis using the EQ-5D-5L, AQoL-8D, EQ-5D-5L-psychosocial, and SF-6D: implications for health economic evaluation models

    Background and aims

    Relapses are an important clinical feature of multiple sclerosis (MS) that result in temporary negative changes in quality of life...

    Hasnat Ahmad, Julie A. Campbell, ... Andrew J. Palmer in Quality of Life Research
    Article Open access 31 July 2023
  16. EQ-5D-5L Population Norms for Italy

    Objectives

    This study aimed to provide normative data obtained in response to the EQ-5D-5L questionnaire in Italy and compare this with data from...

    Michela Meregaglia, Francesco Malandrini, ... Claudio Jommi in Applied Health Economics and Health Policy
    Article Open access 25 November 2022
  17. Psychometric performance of the Chichewa versions of the EQ-5D-Y-3L and EQ-5D-Y-5L among healthy and sick children and adolescents in Malawi

    Objectives

    The EuroQol Group has developed an extended version of the EQ-5D-Y-3L with five response levels for each of its five dimensions...

    Lucky G. Ngwira, Hendramoorthy Maheswaran, ... Sarah C. Smith in Journal of Patient-Reported Outcomes
    Article Open access 09 March 2023
  18. Map** IWQOL-Lite onto EQ-5D-5L and SF-6Dv2 among overweight and obese population in China

    Purpose

    To develop the map** functions from the Impact of Weight on Quality of Life-Lite (IWQOL-Lite) scores onto the EQ-5D-5L and SF-6Dv2 utility...

    Weihua Guo, Shitong **e, ... **g Wu in Quality of Life Research
    Article 03 January 2024
  19. Understanding the measurement relationship between EQ-5D-5L, PROMIS-29 and PROPr

    Purpose

    Many generic patient-reported instruments are available for the measurement of health outcomes, including EQ-5D-5L, and the Patient-Reported...

    Brendan J. Mulhern, Tianxin Pan, ... Nancy J. Devlin in Quality of Life Research
    Article Open access 22 June 2023
  20. Healthcare consumer acceptability of routine use of the EQ-5D-5L in clinical care: a cross-sectional survey

    Purpose

    Patient reported outcome measures, such as the EQ-5D-5L, provide a measure of self-perceived health status or health-related quality of life....

    David A. Snowdon, Taya A. Collyer, ... Nadine E. Andrew in Quality of Life Research
    Article Open access 07 February 2024
Did you find what you were looking for? Share feedback.